MedLife announces its financial results for the third quarter of this year. MedLife Group recorded in Q3 2022 a pro-forma consolidated turnover of 1.3 billion RON, increasing by 27 percent compared to the same period of the last year. According to company representatives, the reported pro-forma turnover does not include two important acquisitions: Muntenia Hospital and Provita Group, which are currently submitted to approval by the Competition Council.

With a constant increase of the market share in all regions of the country, MedLife has once again proved the ability of a healthy business, to adapt regardless of the context. Despite the high inflation and the increase in consumer costs, the Romanian Group recorded in Q3 2022 a double-digit advance for all business segments. The best performing divisions were the clinics and the hospitals, with increases of 50 percent and 15 percent, respectively, results that reflect the effects of the almost two years of the pandemic, during which Romanians postponed their visits to the doctor, for fear of infection or due to restrictions.

“In a context marked by numerous uncertainties and accelerated inflation throughout the world, and implicitly at locally, MedLife once again proves its extraordinary ability to adapt, continuing the sustained pace of development at national level. Regardless of the circumstances, our business decisions are governed by the patient needs. Health does not take into account war, inflation or economic crisis, that’s why we continued our efforts to offer customized solutions both for the employees of almost 10,000 companies we have in our portfolio, and for the millions of patients who cross the threshold of our units year after year”, stated Dorin Preda, Executive Director of MedLife Group.